TikTok users are increasingly turning to a plant-based extract called Volufiline to combat the facial gauntness associated with rapid weight loss. While social media influencers claim the topical cream restores facial volume, medical professionals remain highly skeptical of its ability to reach deep fat cells.

Advertisement

The hollow-cheeked reality of GLP-1 rapid weight loss

Rapid weight loss from drugs like Wegovy and Mounjaro often leads to 'Ozempic face,' charactreized by a sudden loss of facial volume. As reported by the source, a study in the Journal of Clinical Medicine linked this phenomenon to the speed of weight loss, which can see patients lose a fifth of their body weight in a year. This rapid physiological shift often manifests in several ways:

  • Hollow cheeks
  • Sagging skin
  • Sunken eyes
  • This physical change has created a massive , desperate market for quick-fix cosmetic solutions that promise to restore what the medication has taken away.

    Sarsasapogenin and the promise of 'filler in a bottle'

    Volufiline, an extract from the Anemarrhena asphodeloides root, has become a viral sensation on TikTok. The ingredient, which contains a compound known as sarsasapogenin, is marketed by users as a way to encourage existing fat cells to hold more volume. some influencers have gone so far as to claim the product can provide cheekboes comparable to those of Bella Hadid.

    Social media users have frequently described the product as "filler in a bottle," sharing before-and-after videos to support their claims. one user with polyendocrine metabolic ovarian syndrome even reported seeing visible changes after using the product twice a day for just two weeks.

    A 2.2 per cent volume increase in a small-scale study

    The scientific backing for Volufiline relies heavily on a study conducted by its manufacturer, Croda . According to the report, this study involved 28 women who applied the extract to one breast for nearly two months, resulting in an aveage volume increase of 2 .2 per cent in the treated area compared to the untreated side.

    While these numbers may sound promising to a consumer, dermatologists warn that a study involving breast tissue cannot be used to validate facial rejuvenation. The jump from localized breast volume to facial fat restructuring is a significant scientific leap that remains unproven.

    Dr. Payne's skepticism regarding topical fat absorption

    Medical experts like Dr. Christopher Rowland Payne from The London Clinic question the fundamental mechanics of the product. Dr. Payne argues that it is "almost not possible" for a topical cream to penetrate deeply enough into the skin to reach fat cells and significantly increase their volume. This leaves several critical questions unanswered:

    • Is the perceived "plumping" merely a result of increased skin hydration rather than actual fat cell expansion?
    • How long do these visual effects last compared to professional, long-term treatments?
    • Can a topical agent truly mimic the results of clinical lipofilling?
    • Dr. Sweta Rai, a consultant dermatologist at King's College Hospital, also cautioned the public to take viral trends with a "pinch of salt," noting that the medical possibility of a cream replacing an injection for volumisation is highly questionable.

      Lipofilling and fillers as the medical standard

      Clinical procedures remain the primary recommendation for those suffering from significant facial volume loss. Dr. Payne suggests that patients experiencing gauntness due to GLP-1 agonist treatments should first seek medical advice to ensure their medication dosage is not causing excessive weight loss.

      For those seeking permanent or significant structural changes,doctors point to established medical interventions. These include lipofilling—the process of taking fat from a diet-resistant part of the body and injecting it into the face—or standard filler injections to target specific gaunt areas.